ViroGates A/S (OCSE:VIRO) EV-to-Revenue : 5.00 (As of May. 11, 2024)

View and export this data going back to 2018. Start your Free Trial

What is ViroGates A/S EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, ViroGates A/S's enterprise value is kr37.16 Mil. ViroGates A/S's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr7.43 Mil. Therefore, ViroGates A/S's EV-to-Revenue for today is 5.00.

The historical rank and industry rank for ViroGates A/S's EV-to-Revenue or its related term are showing as below:

OCSE:VIRO' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.64 Med: 26.77 Max: 144.36
Current: 5

During the past 8 years, the highest EV-to-Revenue of ViroGates A/S was 144.36. The lowest was 2.64. And the median was 26.77.

OCSE:VIRO's EV-to-Revenue is ranked worse than
65.38% of 826 companies
in the Medical Devices & Instruments industry
Industry Median: 3.265 vs OCSE:VIRO: 5.00

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-11), ViroGates A/S's stock price is kr6.84. ViroGates A/S's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr1.47. Therefore, ViroGates A/S's PS Ratio for today is 4.65.

ViroGates A/S EV-to-Revenue Historical Data

The historical data trend for ViroGates A/S's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViroGates A/S EV-to-Revenue Chart

ViroGates A/S Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

17.47

41.27

53.51

8.18

4.02

ViroGates A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															11.53	6.15	7.31	4.02	4.70

Competitive Comparison of ViroGates A/S's EV-to-Revenue

For the Medical Devices subindustry, ViroGates A/S's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ViroGates A/S's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ViroGates A/S's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where ViroGates A/S's EV-to-Revenue falls into.

ViroGates A/S EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

ViroGates A/S's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	37.155	/	7.432
	=	5.00

ViroGates A/S's current Enterprise Value is kr37.16 Mil.
ViroGates A/S's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr7.43 Mil.

ViroGates A/S (OCSE:VIRO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

ViroGates A/S's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	6.84	/	1.471
	=	4.65

ViroGates A/S's share price for today is kr6.84.
ViroGates A/S's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.47.

ViroGates A/S EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of ViroGates A/S's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

ViroGates A/S (OCSE:VIRO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViroGates A/S (OCSE:VIRO) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Banevaenget 13, Birkerod, DNK, DK-3460

Website

https://www.virogates.com

ViroGates A/S is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.

ViroGates A/S (OCSE:VIRO) Headlines

No Headlines